Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2022 · 10-Q
Revenue$228.53M$228.53M+16.8% vs Q1 2021 Net Income-$4.45M-$4.45MN/M vs Q1 2021 EPS Diluted-$0.09-$0.09N/M vs Q1 2021 Gross Profit$108,085,000+20.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow-$1,680,000N/M Free Cash Flowderived-$15,599,000N/M Margins · derivedGross margin47.3%+1.3 pt vs Q1 2021
Operating margin0.6%−5.4 pt vs Q1 2021
Net margin-1.9%−7.3 pt vs Q1 2021
ended Jul 3, 2021 · filed Aug 11, 2021 · 39 d after period end